The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The Advent of Generative Chemistry
Open accessAbstract
Generative adversarial networks (GANs), first published in 2014, are among the most important concepts in modern artificial intelligence (AI). Bridging deep learning and game theory, GANs are used to generate or “imagine” new objects with desired properties. Since 2016, multiple GANs with reinforcement learning (RL) have been successfully applied in pharmacology for de novo molecular design. Those techniques aim at a more efficient use of the data and a better exploration of the chemical space. We review recent advances for the generation of novel molecules with desired properties with a focus on the applications of GANs, RL, and related techniques. We also discuss the current limitations and challenges in the new growing field of generative chemistry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The development of ultra-large chemical libraries (94) and generative chemistry methods, particularly those based on Generative Adversarial Networks (GANs), have significantly expanded the possibilities for hit generation and drug discovery.”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochreiter, S., & Schmidhuber, J. (1997) · Neural Computation · doi:10.1162/neco.1997.9.8.1735 · Cited by 102,318
Auto-Encoding Variational Bayes
Kingma, D. P., & Welling, M. (2013) · arXiv · doi:10.48550/arxiv.1312.6114 · Cited by 20,067
A Brief Survey of Deep Reinforcement Learning
Arulkumaran, K., Deisenroth, M. P., Brundage, M., & Bharath, A. A. (2017) · arXiv · doi:10.48550/arxiv.1708.05866 · Cited by 4,733
Deep Reinforcement Learning: A Brief Survey
Arulkumaran, K., Deisenroth, M. P., Brundage, M., & Bharath, A. A. (2017) · IEEE Signal Processing Magazine · doi:10.1109/msp.2017.2743240 · Cited by 4,733
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Generative Adversarial Networks
Drori, I. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108891530.013 · Cited by 2,557
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Mureşan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,397
Inverse molecular design using machine learning: Generative models for matter engineering
Sánchez-Lengeling, B., & Aspuru‐Guzik, A. (2018) · Science · doi:10.1126/science.aat2663 · Cited by 2,177
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
NIPS 2016 Tutorial: Generative Adversarial NetworksPreprint
Goodfellow, I. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1701.00160 · Cited by 2,048
Shivakumar, D., Williams, J., Wu, Y., Damm, W., Shelley, J. C., & Sherman, W. (2010) · Journal of Chemical Theory and Computation · doi:10.1021/ct900587b · Cited by 1,945
Ertl, P., & Schuffenhauer, A. (2009) · Journal of Cheminformatics · doi:10.1186/1758-2946-1-8 · Cited by 1,939
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.
Gómez‐Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera‐Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru‐Guzik, A. (2018) · Cambridge University Engineering Department Publications Database · doi:10.17863/cam.34134 · Cited by 1,813
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Molecular graph convolutions: moving beyond fingerprints
Kearnes, S., McCloskey, K., Berndl, M., Pande, V., & Riley, P. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9938-8 · Cited by 1,631
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573
Self-citationGenerating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Tutorial on Variational Autoencoders
Doersch, C. (2016) · arXiv · doi:10.48550/arxiv.1606.05908 · Cited by 1,470
Molecular de-novo design through deep reinforcement learning
Olivecrona, M., Blaschke, T., Engkvist, O., & Chen, H. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0235-x · Cited by 1,443
Deep reinforcement learning for de novo drug design
Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,433
HANSCH, C., MALONEY, P. P., FUJITA, T., & MUIR, R. M. (1962) · Nature · doi:10.1038/194178b0 · Cited by 1,056
Junction Tree Variational Autoencoder for Molecular Graph GenerationPreprint
Jin, W., Barzilay, R., & Jaakkola, T. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1802.04364 · Cited by 1,053
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
The Process of Structure-Based Drug Design
Anderson, A. C. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.09.002 · Cited by 965
Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., Veselov, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565644 · Cited by 849
Self-citationAutomated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Reymond, J.-L. (2015) · Accounts of Chemical Research · doi:10.1021/ar500432k · Cited by 720
Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation ModelsPreprint
Guimaraes, G. L., Sánchez-Lengeling, B., Outeiral, C., Farias, P. L. C., & Aspuru‐Guzik, A. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1705.10843 · Cited by 702
Applications of Deep Learning in Biomedicine
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701
Self-citationDeep learning for molecular design—a review of the state of the art
Elton, D. C., Boukouvalas, Z., Fuge, M. D., & Chung, P. W. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00039a · Cited by 683
Organic synthesis in a modular robotic system driven by a chemical programming language
Steiner, S., Wolf, J. B., Glatzel, S., Andreou, A., Granda, J. M., Keenan, G., Hinkley, T., Aragón-Camarasa, G., Kitson, P. J., Angelone, D., et al. (2018) · Science · doi:10.1126/science.aav2211 · Cited by 652
Wainberg, M., Merico, D., Delong, A., & Frey, B. J. (2018) · Nature Biotechnology · doi:10.1038/nbt.4233 · Cited by 596
Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587
Self-citationEntropy-Enthalpy Compensation: Role and Ramifications in Biomolecular Ligand Recognition and Design
Chodera, J. D., & Mobley, D. L. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130318 · Cited by 531
Generative Recurrent Networks for De Novo Drug Design
Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2017) · Molecular Informatics · doi:10.1002/minf.201700111 · Cited by 494
MolGAN: An implicit generative model for small molecular graphs
De Cao, N., & Kipf, T. (2018) · arXiv · doi:10.48550/arxiv.1805.11973 · Cited by 442
Molecular generative model based on conditional variational autoencoder for de novo molecular design
Lim, J., Ryu, S., Kim, J. W., & Kim, W. Y. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0286-7 · Cited by 421
Application of Generative Autoencoder in De Novo Molecular Design
Blaschke, T., Olivecrona, M., Engkvist, O., Bajorath, J., & Chen, H. (2018) · Molecular Informatics · doi:10.1002/minf.201700123 · Cited by 411
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Lane, E., Asadulaev, A., Ivanenkov, Y. A., Aladinskiy, V., Sánchez-Lengeling, B., Aspuru‐Guzik, A., & Zhavoronkov, A. A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 388
Self-citationDe Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
Kadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350
Self-citationWater Networks Contribute to Enthalpy/Entropy Compensation in Protein–Ligand Binding
Breiten, B., Lockett, M. R., Sherman, W., Fujita, S., Al-Sayah, M. H., Lange, H., Bowers, C. M., Heroux, A., Krilov, G., & Whitesides, G. M. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4075776 · Cited by 341
SeqGAN: Sequence Generative Adversarial Nets with Policy GradientPreprint
Yu, L., Zhang, W., Wang, J., et al. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1609.05473 · Cited by 292
Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery
Polykovskiy, D., Zhebrak, A., Vetrov, D., Ivanenkov, Y., Aladinskiy, V., Mamoshina, P., Bozdaganyan, M., Aliper, A., Zhavoronkov, A., & Kadurin, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00839 · Cited by 278
Self-citationAssessing the impact of generative AI on medicinal chemistry
Walters, W. P., & Murcko, M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0418-2 · Cited by 262
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
Hartenfeller, M., Zettl, H., Walter, M., Rupp, M., Reisen, F., Proschak, E., Weggen, S., Stark, H., & Schneider, G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002380 · Cited by 251
How to explore chemical space using algorithms and automation
Gromski, P. S., Henson, A., Granda, J. M., & Cronin, L. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-018-0066-y · Cited by 247
Artificial intelligence for aging and longevity research: Recent advances and perspectives
Zhavoronkov, A., Mamoshina, P., Vanhaelen, Q., Scheibye-Knudsen, M., Moskalev, A., & Aliper, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.003 · Cited by 246
Self-citationAdversarial Threshold Neural Computer for Molecular de Novo Design
Lane, E., Asadulaev, A., Vanhaelen, Q., Ivanenkov, Y. A., Aladinskaya, A. V., Aliper, A., & Zhavoronkov, A. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01137 · Cited by 226
Self-citationCURRENT PROGRESS IN STRUCTURE-BASED RATIONAL DRUG DESIGN MARKS A NEW MINDSET IN DRUG DISCOVERY
Lounnas, V., Ritschel, T., Kelder, J., McGuire, R., Bywater, R. P., & Foloppe, N. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201302011 · Cited by 220
Artificial Intelligence for Drug Discovery, Biomarker Development, and Generation of Novel Chemistry
Zhavoronkov, A. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00930 · Cited by 200
Self-citationSánchez-Lengeling, B., Outeiral, C., Guimaraes, G. L., & Aspuru‐Guzik, A. (2017) · ChemRxiv · doi:10.26434/chemrxiv.5309668.v3 · Cited by 195
Artificial Intelligence in Drug Discovery
Sellwood, M. A., Ahmed, M., Segler, M., & Brown, N. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0212 · Cited by 186
Automated De Novo Drug Design: Are We Nearly There Yet?
Schneider, G., & Clark, D. E. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814681 · Cited by 173
Molecular Generation with Recurrent Neural Networks (RNNs)Preprint
Bjerrum, E. J., & Threlfall, R. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1705.04612 · Cited by 169
De Novo Design at the Edge of Chaos
Schneider, P., & Schneider, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01849 · Cited by 168
The enumeration of chemical space
Reymond, J., Ruddigkeit, L., Blum, L. C., & van Deursen, R. (2012) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1104 · Cited by 147
Deep Learning for Molecular Generation
Xu, Y., Lin, K., Wang, S., Wang, L., Cai, C., Song, C., Lai, L., & Pei, J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0358 · Cited by 140
The drug-maker's guide to the galaxy
Mullard, A. (2017) · Nature · doi:10.1038/549445a · Cited by 139
A Real-World Perspective on Molecular Design
Kuhn, B., Guba, W., Hert, J., Banner, D. W., Bissantz, C., Ceccarelli, S., Haap, W. J., Körner, M., Kuglstatter, A., Lerner, C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01875 · Cited by 120
Matched Molecular Pair Analysis in Short: Algorithms, Applications and Limitations
Tyrchan, C., & Evertsson, E. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.12.003 · Cited by 112
3D Molecular Representations Based on the Wave Transform for Convolutional Neural Networks
Kuzminykh, D., Polykovskiy, D. A., Kadurin, A., Zhebrak, A., Baskov, I., Nikolenko, S., Shayakhmetov, R., & Zhavoronkov, A. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01134 · Cited by 107
Self-citationIn silico generation of novel, drug-like chemical matter using the LSTM neural networkPreprint
Ertl, P., Lewis, R. A., Martin, É., & Polyakov, V. R. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1712.07449 · Cited by 93
Multi‐Objective Molecular De Novo Design by Adaptive Fragment Prioritization
Reutlinger, M., Rodrigues, T., Schneider, P., & Schneider, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310864 · Cited by 89
Building a virtual ligand screening pipeline using free software: a survey
Glaab, E. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv037 · Cited by 85
Computational Chemical Synthesis Analysis and Pathway Design
Feng, F., Lai, L., & Pei, J. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00199 · Cited by 74
Firth, N. C., Atrash, B., Brown, N., & Blagg, J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00073 · Cited by 61
Blind Prediction of Charged Ligand Binding Affinities in a Model Binding Site
Rocklin, G. J., Boyce, S. E., Fischer, M. M., Fish, I., Mobley, D. L., Shoichet, B. K., & Dill, K. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.030 · Cited by 58
Molecular Generation for Desired Transcriptome Changes With Adversarial Autoencoders
Shayakhmetov, R., Kuznetsov, M., Zhebrak, A., Kadurin, A., Nikolenko, S., Aliper, A. M., & Polykovskiy, D. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00269 · Cited by 48
Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets
Weiss, D. R., Karpiak, J. D., Huang, X., Sassano, M. F., Lyu, J., Roth, B. L., & Shoichet, B. K. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00718 · Cited by 46
Multidimensional De Novo Design Reveals 5‐HT2B Receptor‐Selective Ligands
Rodrigues, T., Hauser, N., Reker, D., Reutlinger, M., Wunderlin, T., Hamon, J., Koch, G., & Schneider, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201410201 · Cited by 41
Multidimensional Design of Anticancer Peptides
Lin, Y., Lim, Y. F., Russo, E., Schneider, P., Bolliger, L., Edenharter, A., Altmann, K., Halin, C., Hiss, J. A., & Schneider, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504018 · Cited by 40
Self-citationErratum: Generative Recurrent Networks for De Novo Drug Design.
Gupta, A., Müller, A. T., Huisman, B. J. H., Fuchs, J. A., Schneider, P., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201880141 · Cited by 40
De novo design – hop(p)ing against hope
Schneider, G. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.06.001 · Cited by 39
Steering Target Selectivity and Potency by Fragment‐Based De Novo Drug Design
Rodrigues, T., Kudoh, T., Roudnicky, F., Lim, Y. F., Lin, Y., Koch, C. P., Seno, M., Detmar, M. J., & Schneider, G. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201304847 · Cited by 23
Self-citationEvaluation of protein–ligand affinity prediction using steered molecular dynamics simulations
Okimoto, N., Suenaga, A., & Taiji, M. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1251851 · Cited by 21
Research works printed but not linked: 1
- Maziarka, Ł.; et al. Mol-CycleGAN - a generative model for molecular optimization. arXiv (Machine Learning), February 6, 2019, 1902.02119, ver. 1. https://arxiv.org/abs/1902.02119. · arXiv
Cited by
Sorted by citations
Computational approaches streamlining drug discovery
Sadybekov, A., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,424
Combining Machine Learning and Computational Chemistry for Predictive Insights Into Chemical Systems
Keith, J. A., Vassilev-Galindo, V., Cheng, B., Chmiela, S., Gastegger, M., Müller, K.-R., & Tkatchenko, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00107 · Cited by 849
Artificial intelligence in drug development
Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G. L., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 585
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Jackson, I., Ivanov, D., Dolgui, A. B., & Namdar, J. (2024) · International Journal of Production Research · doi:10.1080/00207543.2024.2309309 · Cited by 567
Metadata
- Authors
- Vanhaelen, Q., Lin, Y.-C., & Zhavoronkov, A.
- Affiliations
- Insilico Medicine Hong Kong Ltd , Pak Shek Kok , ,
- Corresponding author
- Vanhaelen, Quentin
- Venue
- ACS Medicinal Chemistry Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-07-14
- Volume
- 11
- Issue
- 8
- Pages
- 1496-1505
- ISSN
- 1948-5875 (ISSN-L)
- PMC
- PMC7429972
- OpenAlex
- W3043461363
- Cited by
- 151
- References
- 76
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 32 · 2023: 26 · 2022: 16 · 2021: 30 · 2020: 2
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- ACS Medicinal Chemistry Letters (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Generative Adversarial Networks and Image Synthesis
- Keywords
- generative chemistry, generative adversarial networks, reinforcement learning, de novo molecular design, drug discovery, chemical space exploration, molecular property prediction, generative models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
